Metvixia

Active Ingredient(s): Methyl Aminolevulinate Hydrochloride
FDA Approved: * July 27, 2004
Pharm Company: * PHOTOCURE ASA
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Metvixia Overview

Methyl aminolevulinate (MAL) is a drug used as a sensitizer in photodynamic therapy. It is a prodrug that is metabolized to protoporphyrin IX. It is marketed as Metvix. Metvix cream is applied topically and some time later the skin is illuminated with a proprietary red light (630nm) source (medical lamp 'Aktilite') to activate the photosensitiser. Metvix is developed by Photocure and Galderma has bought all rights to Metvix.[1] Approvals and indications Interim result of...

Read more Metvixia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methyl_aminolevulinate

Recent Metvixia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methyl Aminolevulinate Hydrochloride
  • Cream: 16.8%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Methyl Aminolevulinate Hydrochloride or a similar ingredient: (3 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA